Testing Non-nutritive Sweetener Labels in Chile
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different warning labels on products that contain non-nutritive sweeteners (NNS), which are often used as sugar substitutes, can help parents in Chile make better choices for their children. The researchers want to find out if these labels make it easier for parents to spot products with NNS and whether they influence what parents choose to buy—whether it’s unsweetened, sugar-sweetened, or sweetened with NNS.
To participate, you need to be at least 18 years old and a parent or guardian of a child aged 2 to 14 who has not been diagnosed with diabetes or related conditions. If you join the study, you will be randomly assigned to see one of three types of labels on four similar products: one without any sweeteners, one with sugar, one with NNS, and one with both sugar and NNS. You will identify which products contain NNS and choose which one you would buy for your child. This study aims to better understand how labeling affects choices, which could help improve food labeling in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- • Residing in Chile
- Exclusion Criteria:
- • Less than 18 years old
- • Not parent or guardian of child between 2-14 years old who has never been diagnosed with diabetes, high blood sugar, pre-diabetes or insulin resistance
- • Not residing in Chile
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Lindsey Smith Taillie, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported